トルコのトップキイトルーダ療法医師と価格を比較。こちらで最適なマッチングを見つけてください

医師サービスで最良価格の国を選択

トップ各国のキイトルーダ療法価格を比較

国をタップしてトップ医師と価格を表示

Turkey

Ukraine

South Korea

Mexico

Czech Republic

Canada

$3,300 - $10,000

$4,500 - $8,000

$5,200 - $8,500

$7,000 - $11,000

$7,500 - $10,500

$7,800 - $11,200

$2,000

$4,000

$6,000

$8,000

$10,000

$12,000

トルコのキイトルーダ療法でBookimed患者が実際に支払う費用

最も人気の範囲

$1.5K

$3K

$4.5K

$6K+

$7.5K+

$9K+

$10.5K+

$12K+

$1,100 – $4,200

ほとんどの患者がこの範囲内でお支払いです

正確な費用は選択された医師、技術、治療部位、お客様の個別ニーズによって決まります

お客様のケースに正確な見積もりを取得

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

Muhammed Gomec

17年の経験
所在地：トルコ, スィヴァス
クリニック：
5.0
Medicana Sivas Hospital

診察

お問い合わせください

Bookimed洞察：トルコのトップキイトルーダ療法専門家（2026）

Bookimedはトルコのキイトルーダ療法リクエスト23件を調整し、1名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています

順位	医師	経験	適合する方	特色	クリニックと所在地	診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Who are the leading medical oncologists in Turkey specializing in Keytruda (pembrolizumab) immunotherapy?

Turkey serves as an international oncology hub where board-certified medical oncologists provide personalized pembrolizumab regimens. Leading specialists at JCI-accredited facilities integrate advanced biomarker testing to target specific malignancies. Doctors often hold international fellowships and ESMO certifications to deliver high-quality immunotherapy protocols.

Dr. Yesim Yildirim: ESMO-certified professor with immunooncology training from Mount Vernon Cancer Centre in London.
Dr. Bulent Karagoz: Specializes in tumor immunology and targeted therapies with 20+ years of oncology experience.
Dr. Mustafa Solak: Features clinical expertise from the MD Anderson Cancer Center in the United States.
Dr. Abdullah Sakin: Leads medical oncology at a major university hospital focusing on immunotherapy treatments.

Bookimed Expert Insight: Data shows that top Turkish oncologists like Dr. Yesim Yildirim and Dr. Bulent Karagoz have authored 40+ to 80+ scientific publications. This research focus often includes tumor biology and immunotherapy response. At Anadolu Medical Center, these specialists follow Johns Hopkins Medicine protocols for checkpoint inhibitor administration.

Patient Consensus: Patients note that major hospitals focus on honest care rather than unnecessary tests. They appreciate how doctors explain immunotherapy side effects clearly. Coordination with professional guides at facilities like Florence Nightingale makes the difficult treatment journey feel more supportive.

Which criteria do Turkish doctors use to determine if a patient is eligible for Keytruda?

Turkish oncologists determine Keytruda eligibility using advanced biomarker status and tumor pathology. Doctors prioritize PD-L1 expression levels along with MSI-H or dMMR status. They evaluate performance scores and organ health to confirm the immune system can tolerate intensive therapy. Cancer stage and prior treatment history also guide these clinical decisions.

Biomarker testing: Doctors verify PD-L1 expression through TPS or CPS scores for targeted response.
Molecular profile: Testing confirms MSI-H or dMMR status across various solid tumor types.
Performance status: Patients must have an ECOG score of 0 or 1 for treatment.
Organ function: Evaluations include renal, hepatic, and cardiovascular panels to avoid side effects.

Bookimed Expert Insight: Expert oncologists in Turkey often hold specialized certifications from the European Society for Medical Oncology (ESMO). For example, Dr. Seref Komurcu and Dr. Yesim Yildirim at Anadolu Medical Center are both ESMO-certified. This international accreditation means they follow standardized global protocols for matching immunotherapy to specific genetic tumor profiles.

Patient Consensus: Patients note that having complete pathology and molecular reports is essential before arriving in Turkey. They often feel relieved when doctors explain the results of genetic testing simply. Many were surprised that physical fitness and prior chemo history mattered as much as the cancer stage.

How do doctors in Turkey manage the specific side effects of Pembrolizumab?

Turkish oncologists manage Pembrolizumab side effects by following international protocols to identify and treat immune-related adverse events. They use a multidisciplinary approach involving specialists like endocrinologists and pulmonologists. Specialists often pause treatment and start steroid therapy to resolve complications before they escalate.

Multidisciplinary boards: Teams of specialists collaborate to monitor multi-organ toxicities and coordinate care.
Toxicity grading: Doctors use standard scales to dictate interventions like holding doses or starting steroids.
Baseline profiling: Clinicians perform diagnostic screenings and liver panels before starting the first infusion.
Hormonal management: Specialists provide long-term hormone replacement for endocrine side effects while continuing therapy.

Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center benefit from high-level international training and academic leadership. For example, Dr. Yesim Yildirim is ESMO-certified with advanced training from Mount Vernon Cancer Center in London. This global expertise allows doctors to apply the latest clinical trials and research-based protocols when managing complex immunotherapy reactions.

Patient Consensus: Patients note that even minor fatigue or skin rashes require immediate reporting to the medical team. They emphasize that managing side effects involves regular lab tests rather than a one-time fix. Many feel safer knowing their doctors respond quickly to symptom logs and coordinate with other specialists.

What administrative and medical steps must international patients complete with Turkish doctors to begin treatment?

International patients must complete an official medical evaluation and secure state-regulated documentation to begin Keytruda treatment in Turkey. Specialized oncologists require a thorough review of pathology reports and English-translated medical history. Patients must also obtain a formal invitation letter from an accredited facility to process medical visas.

Medical record review: Upload diagnostic summaries and tumor biology reports for online consultation.
Official invitation letter: Secure a hospital-signed document detailing the planned immunotherapy schedule.
In-person oncology exam: Complete a physical evaluation with a Turkish board-certified oncologist.
Confirmation diagnostics: Run local blood tests and radiological imaging to verify dosages.

Bookimed Expert Insight: Turkish oncology centers often combine international standards with diverse specialized training. For example, Dr. Yesim Yildirim at Anadolu Medical Center trained in both Israel and at the Mount Vernon Cancer Center in London. This international exposure allows doctors to adapt Keytruda protocols for complex cases using various global methodologies.

Patient Consensus: Patients note it is simpler than expected to get treatment started once documents are ready. Many felt relieved having an English-speaking coordinator handle the paperwork at the hospital. They often mention that seeing the doctor face-to-face for the first time helped clear up any lingering questions about the therapy steps.

スィヴァスで最高のキイトルーダ療法医師 - トップ1名の医師

トルコの3名のトップキイトルーダ療法専門家から見積もりを取得